Cotinga Pharmaceuticals Azioni in circolazione
Cos'è Azioni in circolazione di Cotinga Pharmaceuticals?
Azioni in circolazione di Cotinga Pharmaceuticals, Inc. è 21.986M
Qual è la definizione di Azioni in circolazione?
Le azioni in circolazione sono tutte le azioni di una società o di un'attività finanziaria che sono state autorizzate, emesse e acquistate dagli investitori e sono detenute da loro.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Azioni in circolazione di aziende nel Health Care settore su TSXV rispetto a Cotinga Pharmaceuticals
Cosa fa Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Aziende con azioni in circolazione simili a Cotinga Pharmaceuticals
- Anglo African Agriculture Plc ha Azioni in circolazione di 21.966M
- Kennametal India ha Azioni in circolazione di 21.978M
- Kennametal India ha Azioni in circolazione di 21.978M
- Masonite International Corp ha Azioni in circolazione di 21.984M
- Broadwind Inc ha Azioni in circolazione di 21.986M
- Amesite ha Azioni in circolazione di 21.986M
- Cotinga Pharmaceuticals ha Azioni in circolazione di 21.986M
- MGP Ingredients ha Azioni in circolazione di 21.988M
- Ram Ratna Wires ha Azioni in circolazione di 22.000M
- Umang Dairies ha Azioni in circolazione di 22.003M
- Umang Dairies ha Azioni in circolazione di 22.003M
- Tonix Pharmaceuticals Corp ha Azioni in circolazione di 22.004M
- Greif Bros ha Azioni in circolazione di 22.008M